Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

β-Blockers for the Treatment of Misophonia and Misokinesia

Webb, Jadon · 2022 · Clinical Neuropharmacology

Abstract

Misophonia is an adverse physical and emotional reaction to certain repetitive trigger sounds, usually generated by other people. Misokinesia refers to visual triggers that are sometimes (but not always) related to trigger sounds. Despite how common and disabling these conditions can be, medication treatment of misophonia and misokinesia is largely unexplored. We present the first case of using a β-blocker (propranolol) to successfully treat a patient experiencing misophonia and misokinesia. A moderate dose (60 mg) of propranolol completely eliminated multiple auditory and visual trigger symptoms related to other people eating. His trigger response symptoms included overwhelming negative emotions and prominent sympathetic overactivity (fight-or-flight response). These symptoms were so severe that he had avoided most meals with friends and family for the past several years. Propranolol eliminated the emotional and physiological effects of both the auditory and visual triggers, with an Amsterdam Misophonia Scale score reduction from 15 to 2. This enabled him to resume eating meals with family and friends with no distress. The medication was well tolerated. In summary, we report the novel finding that β-blockers were markedly effective at treating the physical and emotional symptoms of a patient with misophonia and misokinesia. This suggests a novel treatment approach for these conditions.

Overview

Integrity signals

Registry

Crossref · 10.1097/wnf.0000000000000492

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 4 references

Cited by

See all 18

Metadata

Authors
Webb, J.
Affiliations
Yale University (US)
Corresponding author
Webb, Jadon
Venue
Clinical Neuropharmacology
Published
2022-01
Volume
45
Issue
1
Pages
13-14
ISSN
  • 0362-5664 (ISSN-L)
  • 1537-162X
OpenAlex
W4205560768
Cited by
18
References
4
Citations by year
2026: 2 · 2025: 3 · 2024: 8 · 2023: 1 · 2022: 4
FWCI
2.42
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
  • Physical Sciences › Physics and Astronomy › Acoustics and Ultrasonics › Noise Effects and Management
  • Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
Keywords
misophonia, propranolol, beta-blockers, sympathetic hyperactivity, fight-or-flight response, social avoidance, pharmacotherapy
MeSH terms
Adrenergic beta-Antagonists, Hearing Disorders, Humans, Male, Phobic Disorders, Hyperacusis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: β-Blockers for the Treatment of Misophonia and Misokinesia. https://app.cochat.ai/papers/10.1097/wnf.0000000000000492
The paper
Webb, J. (2022). β-Blockers for the Treatment of Misophonia and Misokinesia. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000492

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.